U.K. Biotech Stocks

AstraZeneca

Market Cap: UK£176.6b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£59.6b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Haleon

Market Cap: UK£35.7b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Hikma Pharmaceuticals

Market Cap: UK£4.3b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally.

Genus

Market Cap: UK£1.2b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

Alliance Pharma

Market Cap: UK£347.6m

Acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.

PureTech Health

Market Cap: UK£332.3m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Oxford Biomedica

Market Cap: UK£287.2m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

MaxCyte

Market Cap: UK£216.3m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Animalcare Group

Market Cap: UK£147.6m

Develops, sells, and distributes licensed veterinary pharmaceuticals and identification products, and services for companion and production animals, and equine veterinary markets in Europe and internationally.

Avacta Group

Market Cap: UK£125.8m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Bioventix

Market Cap: UK£123.7m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Diaceutics

Market Cap: UK£97.2m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

hVIVO

Market Cap: UK£97.0m

Operates as a pharmaceutical service and contract research company in the United Kingdom.

ECO Animal Health Group

Market Cap: UK£36.3m

Develops, registers, and markets pharmaceutical products for animals worldwide.

Futura Medical

Market Cap: UK£30.8m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

Tissue Regenix Group

Market Cap: UK£26.0m

A medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally.

Shield Therapeutics

Market Cap: UK£21.9m

A commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs.

Arecor Therapeutics

Market Cap: UK£15.7m

A biopharmaceutical company, focuses on developing products in diabetes and other indications ion the United Kingdom.

ProBiotix Health

Market Cap: UK£13.8m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Poolbeg Pharma

Market Cap: UK£12.4m

Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.

Synairgen

Market Cap: UK£11.6m

Synairgen plc discovers and develops drugs for respiratory diseases.

IXICO

Market Cap: UK£7.2m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Fusion Antibodies

Market Cap: UK£6.0m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

Verici Dx

Market Cap: UK£5.7m

Develops prognostic and diagnostic tests for kidney transplant patients.

Aptamer Group

Market Cap: UK£5.1m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

Theracryf

Market Cap: UK£4.8m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.

Genflow Biosciences

Market Cap: UK£3.7m

Operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium.

Kanabo Group

Market Cap: UK£2.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

Roquefort Therapeutics

Market Cap: UK£2.2m

A material biotech company, engages in the development of medicines for the treatment of cancer.

ValiRx

Market Cap: UK£1.7m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

N4 Pharma

Market Cap: UK£1.7m

A specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom.

Oncimmune Holdings

Market Cap: UK£1.3m

A precision medicine company, provides autoantibody biomarker profiling in immuno-oncology, autoimmune, and infectious diseases in Europe and internationally.

Physiomics

Market Cap: UK£833.2k

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

LungLife AI

Market Cap: UK£275.9k

A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.